| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 202 | 176 | 325 | 117 | | Cost of Revenue | 109 | 75 | 292 | 130 | | | Gross Profit | 93 | 101 | 33 | (13) | | | Operating Expenses | | Research Development | 2 | 43 | 197 | 461 | | Selling General and Administrative | 575 | 755 | 960 | 1,124 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (484) | (697) | (1,124) | (1,598) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 112 | 75 | 190 | 94 | | Earnings Before Interest And Taxes | (372) | (622) | (938) | (1,427) | | Interest Expense | 457 | 620 | 900 | 599 | | Income Before Tax | (829) | (1,242) | (1,838) | (2,026) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 31 | 64 | (4) | 77 | | | | Net Income From Continuing Ops | (798) | (1,178) | (1,838) | (2,026) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (798) | (1,178) | (1,838) | (2,026) | | Preferred Stock And Other Adjustments | (1) |
-
|
-
| (106) | | | Net Income Applicable To Common Shares | ($799) | ($1,178) | ($1,838) | ($2,132) |
|
0.83% Nasdaq 0.00%
Income Statement
